Skip to content
healthcare.dev

LISDEXAMFETAMINE DIMESYLATE

NDC 70010-211, LISDEXAMFETAMINE DIMESYLATE, capsule, from Granules Pharmaceuticals Inc..

Product NDC
70010-211
Status
Listed
Labeler
Granules Pharmaceuticals Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218987
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70010-211 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE60 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
70010-211-0170010021101100 CAPSULE in 1 BOTTLE (70010-211-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c91c6acf-b68c-4832-a06f-d0fbd6b80457
  • NADAC price for package 70010021101

    GET /v1/drugs/nadac/70010021101

Use it

Look up 70010-211 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70010-211 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70010-211. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.